A 28-year-old woman presents with recurrent stroke-like episodes, seizures, and elevated serum lactate. Muscle biopsy shows ragged red fibers. Genetic testing confirms m.3243A>G mutation in her mtDNA. Her two siblings have the same mutation but with markedly different clinical severity — one is asymptomatic, the other severely affected with early-onset diabetes and deafness. The inheritance pattern marked **A** in the pedigree diagram demonstrates mitochondrial inheritance with heteroplasmy. Which of the following BEST explains why her asymptomatic sibling has not yet developed clinical features despite carrying the same pathogenic mutation?

Explanation

## Why "The mutant mtDNA load in the asymptomatic sibling's tissues is below the tissue-specific threshold required for clinical disease manifestation" is right The clinical anchor is that heteroplasmy — the random segregation of mutant mtDNA molecules into daughter cells during mitotic division — creates variable mutant loads across tissues and siblings. Clinical disease in mitochondrial disorders appears only when the mutant load exceeds a tissue-specific threshold, typically 60–90% (Harrison's 21e, Ch 459). During oogenesis, the mtDNA bottleneck allows an affected mother's eggs to contain anywhere from 0% to 100% mutant mtDNA, so even within a sibship, heteroplasmy load varies dramatically. The asymptomatic sibling inherited a lower proportion of mutant mtDNA molecules; her tissues remain below the threshold needed for stroke-like episodes, lactic acidosis, or seizures. As she ages, mitotic segregation may increase the mutant load in critical tissues, potentially unmasking disease later — this explains variable expressivity within families carrying the same m.3243A>G mutation. ## Why each distractor is wrong - **The asymptomatic sibling inherited a different mtDNA mutation that is protective against MELAS phenotype**: Genetic testing confirmed the SAME m.3243A>G mutation in all three siblings. mtDNA is maternally inherited as a single genome per mitochondrion; protective mutations are not part of the heteroplasmy mechanism in this context. - **The asymptomatic sibling has undergone spontaneous reversion of the m.3243A>G mutation in most of her mitochondria**: Reversion of pathogenic mtDNA mutations is not a recognized mechanism in MELAS. Once acquired, the mutation persists in the mitochondrial genome; what changes is the proportion of mutant vs. wild-type mtDNA (heteroplasmy load), not reversion. - **The asymptomatic sibling's father must have been the carrier, resulting in paternal mitochondrial transmission that causes milder disease**: Mitochondrial DNA is inherited exclusively maternally; paternal mitochondria are ubiquitinated and degraded after fertilization (Harrison's 21e, Ch 459). An affected father NEVER transmits mtDNA mutations to any child. This option contradicts the fundamental biology of mitochondrial inheritance. **High-Yield:** Heteroplasmy + tissue-specific threshold = variable expressivity in mitochondrial disease; siblings with the same mutation can range from asymptomatic to severely affected based on random mtDNA segregation during oogenesis and mitosis. [cite: Harrison's Principles of Internal Medicine 21e Ch 459 (Mitochondrial DNA Diseases); Adams Neurology 12e Ch 37]